Cargando…
Twenty-Four Hour Blood Pressure Response to Empagliflozin and Its Determinants in Normotensive Non-diabetic Subjects
BACKGROUND: Sodium–glucose co-transport 2 inhibitors (SGLT2i) lower blood pressure (BP) in normotensive subjects and in hypertensive and normotensive diabetic and non-diabetic patients. However, the mechanisms of these BP changes are not fully understood. Therefore, we examined the clinical and bioc...
Autores principales: | Zanchi, Anne, Pruijm, Menno, Muller, Marie-Eve, Ghajarzadeh-Wurzner, Arlène, Maillard, Marc, Dufour, Nathalie, Bonny, Olivier, Wuerzner, Grégoire, Burnier, Michel |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8981729/ https://www.ncbi.nlm.nih.gov/pubmed/35391843 http://dx.doi.org/10.3389/fcvm.2022.854230 |
Ejemplares similares
-
Acute and Chronic Effects of SGLT2 Inhibitor Empagliflozin on Renal Oxygenation and Blood Pressure Control in Nondiabetic Normotensive Subjects: A Randomized, Placebo‐Controlled Trial
por: Zanchi, Anne, et al.
Publicado: (2020) -
Blood pressure and vascular determinants of glomerular filtration rate decline in diabetic kidney disease
por: Truscello, Luca, et al.
Publicado: (2023) -
Effects of the SGLT-2 Inhibitor Empagliflozin on Renal Tissue Oxygenation in Non-Diabetic Subjects: A Randomized, Double-Blind, Placebo-Controlled Study Protocol
por: Muller, Marie-Eve, et al.
Publicado: (2018) -
Long-term use and tolerability of irbesartan for control of hypertension
por: Forni, Valentina, et al.
Publicado: (2011) -
Contrast-Enhanced Ultrasonography Enables the Detection of a Cold Pressor Test-Induced Increase in Renal Microcirculation in Healthy Participants
por: Hendriks-Balk, Mariëlle C., et al.
Publicado: (2022)